201 related articles for article (PubMed ID: 32228601)
1. Identification of miRNA-mRNA associations in hepatocellular carcinoma using hierarchical integrative model.
Varghese RS; Zhou Y; Barefoot M; Chen Y; Di Poto C; Balla AK; Oliver E; Sherif ZA; Kumar D; Kroemer AH; Tadesse MG; Ressom HW
BMC Med Genomics; 2020 Mar; 13(1):56. PubMed ID: 32228601
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
Huang DP; Zeng YH; Yuan WQ; Huang XF; Chen SQ; Wang MY; Qiu YJ; Tong GD
Int J Med Sci; 2021; 18(2):335-346. PubMed ID: 33390802
[No Abstract] [Full Text] [Related]
3. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
[TBL] [Abstract][Full Text] [Related]
4. Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.
Zhou X; Dou M; Liu Z; Jiao D; Li Z; Chen J; Li J; Yao Y; Li L; Li Y; Han X
J Immunol Res; 2021; 2021():5518908. PubMed ID: 34426790
[TBL] [Abstract][Full Text] [Related]
5. Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Hepatocellular Carcinoma by Integrated Microarray Analysis.
Lin X; Chen Y
Med Sci Monit Basic Res; 2018 Apr; 24():70-78. PubMed ID: 29706616
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential transcription factors, long noncoding RNAs, and microRNAs associated with hepatocellular carcinoma.
Yan H; Wang Q; Shen Q; Li Z; Tian J; Jiang Q; Gao L
J Cancer Res Ther; 2018 Sep; 14(Supplement):S622-S627. PubMed ID: 30249878
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
[TBL] [Abstract][Full Text] [Related]
9. Identification of the Pathogenic Biomarkers for Hepatocellular Carcinoma Based on RNA-seq Analyses.
Jiang W; Zhang L; Guo Q; Wang H; Ma M; Sun J; Chen C
Pathol Oncol Res; 2019 Jul; 25(3):1207-1213. PubMed ID: 30680535
[TBL] [Abstract][Full Text] [Related]
10. Screening key miRNAs for human hepatocellular carcinoma based on miRNA-mRNA functional synergistic network.
Zhang CJ; Du HJ
Neoplasma; 2017; 64(6):816-823. PubMed ID: 28895405
[TBL] [Abstract][Full Text] [Related]
11. Identification of Potential Diagnostic and Prognostic Pseudogenes in Hepatocellular Carcinoma Based on Pseudogene-miRNA-mRNA Competitive Network.
Yan L; Yue C; Xu Y; Jiang X; Zhang L; Wu J
Med Sci Monit; 2020 May; 26():e921895. PubMed ID: 32457285
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive transcriptomic analyses of tissue, serum, and serum exosomes from hepatocellular carcinoma patients.
Mjelle R; Dima SO; Bacalbasa N; Chawla K; Sorop A; Cucu D; Herlea V; Sætrom P; Popescu I
BMC Cancer; 2019 Oct; 19(1):1007. PubMed ID: 31660891
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel biomarkers for hepatocellular carcinoma using transcriptome analysis.
Xia Q; Li Z; Zheng J; Zhang X; Di Y; Ding J; Yu D; Yan L; Shen L; Yan D; Jia N; Chen W; Feng Y; Wang J
J Cell Physiol; 2019 Apr; 234(4):4851-4863. PubMed ID: 30272824
[TBL] [Abstract][Full Text] [Related]
14. Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma.
Cao D; Wang Y; Li D; Wang L
Crit Rev Eukaryot Gene Expr; 2019; 29(6):539-549. PubMed ID: 32422009
[TBL] [Abstract][Full Text] [Related]
15. A Bayesian two-step integrative procedure incorporating prior knowledge for the identification of miRNA-mRNAs involved in hepatocellular carcinoma.
Denis M; Varghese RS; Barefoot ME; Tadesse MG; Ressom HW
Annu Int Conf IEEE Eng Med Biol Soc; 2022 Jul; 2022():81-86. PubMed ID: 36085997
[TBL] [Abstract][Full Text] [Related]
16. Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
Thurnherr T; Mah WC; Lei Z; Jin Y; Rozen SG; Lee CG
Sci Rep; 2016 Jan; 6():20065. PubMed ID: 26817861
[TBL] [Abstract][Full Text] [Related]
17. Integrative analysis of transcriptome and miRNome unveils the key regulatory connections involved in different stages of hepatocellular carcinoma.
Ramesh V; Ganesan K
Genes Cells; 2016 Sep; 21(9):949-65. PubMed ID: 27465470
[TBL] [Abstract][Full Text] [Related]
18. iSubgraph: integrative genomics for subgroup discovery in hepatocellular carcinoma using graph mining and mixture models.
Ozdemir B; Abd-Almageed W; Roessler S; Wang XW
PLoS One; 2013; 8(11):e78624. PubMed ID: 24223834
[TBL] [Abstract][Full Text] [Related]
19. Identification of a long non‑coding RNA‑mediated competitive endogenous RNA network in hepatocellular carcinoma.
He H; Chen D; Cui S; Piao H; Tang H; Wang X; Ye P; Jin S
Oncol Rep; 2019 Aug; 42(2):745-752. PubMed ID: 31173261
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Poor Prognosis of HCC by Early Warning Model for Co-Expression of miRNA and mRNA Based on Bioinformatics Analysis.
Su ZJ; Lin CC; Pan JH; Zhang JH; Han T; Pan Q
Technol Cancer Res Treat; 2020; 19():1533033820959353. PubMed ID: 33089765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]